Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.5600 (8.1%) ($38.5600 - $38.8300) on Fri. Dec. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.69% (three month average) | RSI | 65 | Latest Price | $38.5600(8.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 2.3% a day on average for past five trading days. | Weekly Trend | HALO advances 5.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(52%) IWO(49%) IWM(47%) IWC(44%) IWN(44%) | Factors Impacting HALO price | HALO will decline at least -1.345% in a week (0% probabilities). VIXM(-28%) UUP(-11%) VXX(-10%) TBT(-3%) GLD(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.345% (StdDev 2.69%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $36.09(6.84%) | 10 Day Moving Average | $34.63(11.35%) | 20 Day Moving Average | $34.25(12.58%) | To recent high | -8.6% | To recent low | 21.2% | Market Cap | $5.27b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |